Glimepiride

 Glimepiride – Full Introduction

Glimepiride

Glimepiride is an oral antihyperglycemic agent belonging to the sulfonylurea class, used primarily in the management of type 2 diabetes mellitus (T2DM). It helps lower blood glucose by stimulating insulin secretion from the pancreatic beta cells.


Drug Class

  • Sulfonylurea

  • Oral antidiabetic agent


Mechanism of Action

Glimepiride works by stimulating pancreatic beta cells to release insulin:

  1. Binds to sulfonylurea receptors (SUR1) on pancreatic beta cells

  2. Closes ATP-sensitive potassium channels

  3. Causes cell depolarization, opening calcium channels

  4. Calcium influx triggers insulin secretion

Unlike metformin, glimepiride depends on functioning beta cells and may lead to hypoglycemia if insulin release is excessive. It also has mild extrapancreatic effects that improve insulin sensitivity.


Therapeutic Uses

  • Type 2 diabetes mellitus (as monotherapy or in combination with other antidiabetics like metformin)

  • Adjunct therapy when lifestyle modification alone is insufficient


Benefits

  • Effective in lowering fasting and postprandial blood glucose

  • Once-daily dosing improves compliance

  • Can be combined with metformin or insulin for better glucose control


Common Side Effects

  • Hypoglycemia (most common, especially in elderly or renal-impaired patients)

  • Weight gain

  • Nausea or gastrointestinal discomfort

  • Skin rash (rare)


Serious but Rare Side Effects

  • Severe hypoglycemia (can be life-threatening)

  • Hematologic effects (thrombocytopenia, leukopenia – very rare)

  • Liver function abnormalities (rare)

  • Allergic reactions (rash, photosensitivity)


Contraindications & Precautions

  • Type 1 diabetes (requires insulin)

  • Diabetic ketoacidosis

  • Severe hepatic or renal impairment

  • History of sulfonamide allergy

  • Caution in elderly and malnourished patients due to increased hypoglycemia risk


Dosage & Administration

  • Initial dose: 1–2 mg orally once daily with breakfast

  • Titrated up gradually (max 8 mg/day) based on blood glucose response

  • Usually taken once daily to minimize hypoglycemia


Conclusion

Glimepiride is an effective sulfonylurea for controlling blood glucose in type 2 diabetes, especially when beta-cell function is preserved. While it provides potent glycemic control, monitoring for hypoglycemia, weight gain, and renal/liver function is essential.

Post a Comment

0 Comments

Lisinopril